A&G Pharmaceutical - Middle East and Africa Non-Invasive Cancer Diagnostics market
Middle East And Africa Non-Invasive Cancer Diagnostics Market By Techniques, By Therapeutics And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018–2023)
(EMAILWIRE.COM, November 21, 2018 ) A&G’s scientific leadership includes world-leading researchers in the fields of cell biology, immunology, and growth factor research, and the company has broad expertise in molecular biology and biochemistry, providing a solid foundation for engineering new drug/test products that improve cancer detection, treatment, patient survival, and outcomes and deliver on the promise of personalized cancer care.
Their lead drug/test products in development target breast cancer based on a unique biomarker known as GP88, or progranulin (GP88/PGRN), which is produced by breast cancer tumors and is used to help the cancer grow and proliferate. In clinical studies, GP88 has been shown to consistently identify more than 80% of breast cancers—a level significantly higher than any currently available method—and has the potential to detect a number of other cancers from blood samples and tissue biopsies. They are currently focused on a near-term opportunity to complete development of and commercialize two GP88-based breast cancer diagnostic test kits to improve early detection, diagnosis, and treatment of breast cancer. Concurrent with development of GP88 diagnostic kits, A&G is aggressively pursuing development of an associated anti-GP88 monoclonal antibody therapeutic. In addition, the company is expanding its pipeline by screening for monoclonal antibodies that recognize ovarian, pancreatic, prostate, and lung cancer.
Get customized report here:
https://www.marketdataforecast.com/market-reports/middle-east-and-africa-non-invasive-cancer-diagnostics-market-5561/customize-report
Market Trends:
Market Data Forecast has released a report on Middle East and Africa Mental Non-Invasive Cancer Diagnostics market; Breast cancer had the largest market share due to increasing incidence of cancer due aging, and increasing awareness about early cancer diagnosis. Molecular Diagnostics market segment is expected to grow rapidly due to advancements in cancer detection techniques.
Precision Therapeutics, Laboratory Corporation of America Holdings (LabCorp), BIOVIEW Inc., Affymetrix Inc., AVIVA Biosciences Corporation, Quest Diagnostics Incorporated Cancer Genetics Inc., Digene Corporation and Gen-Probe Incorporated, are the other key players in the Middle East and Africa Non-Invasive Cancer Diagnostics market.
For the detailed information please follow the link:
https://www.marketdataforecast.com/market-reports/middle-east-and-africa-non-invasive-cancer-diagnostics-market-5561/
Scope of the Report:
The report offers an extensive examination of the business by giving the estimations of market potential and gauges with most extreme granularity. Along this, the variables persuasive in affecting the market flow and patterns are examined in detail at the item level. Further, the execution of the market at the territorial and nation level is evaluated and the prospects with high development potential are distinguished and discussed.
The key players in the business are profiled giving bits of knowledge on their money related execution, advertise position and development techniques. Similar investigation on prime strategical exercises of the market players depicting the key advancements like mergers and acquisitions, coordinated efforts and an assessment of the focused condition inside the business are given. The report additionally offers an expansive standpoint of the market alongside proposals from industry specialists on the open doors for speculation action.
What else? Aside from the syndicated report, our in-house group has an aptitude and involvement in planning custom reports to meet your particular research needs and help you in settling on very much educated choices.
Contact Info:
Name: Mr. Abhishek Shukla
Email: abhishek@marketdataforecast.com
Organization: MarketDataForecast™
Address: 2nd Floor, Above ICICI Bank, B-44, Rd Number 3, Journalist Colony, Film Nagar, Hyderabad, Telangana 500033, India.
Phone: +1-888-702-9626
Their lead drug/test products in development target breast cancer based on a unique biomarker known as GP88, or progranulin (GP88/PGRN), which is produced by breast cancer tumors and is used to help the cancer grow and proliferate. In clinical studies, GP88 has been shown to consistently identify more than 80% of breast cancers—a level significantly higher than any currently available method—and has the potential to detect a number of other cancers from blood samples and tissue biopsies. They are currently focused on a near-term opportunity to complete development of and commercialize two GP88-based breast cancer diagnostic test kits to improve early detection, diagnosis, and treatment of breast cancer. Concurrent with development of GP88 diagnostic kits, A&G is aggressively pursuing development of an associated anti-GP88 monoclonal antibody therapeutic. In addition, the company is expanding its pipeline by screening for monoclonal antibodies that recognize ovarian, pancreatic, prostate, and lung cancer.
Get customized report here:
https://www.marketdataforecast.com/market-reports/middle-east-and-africa-non-invasive-cancer-diagnostics-market-5561/customize-report
Market Trends:
Market Data Forecast has released a report on Middle East and Africa Mental Non-Invasive Cancer Diagnostics market; Breast cancer had the largest market share due to increasing incidence of cancer due aging, and increasing awareness about early cancer diagnosis. Molecular Diagnostics market segment is expected to grow rapidly due to advancements in cancer detection techniques.
Precision Therapeutics, Laboratory Corporation of America Holdings (LabCorp), BIOVIEW Inc., Affymetrix Inc., AVIVA Biosciences Corporation, Quest Diagnostics Incorporated Cancer Genetics Inc., Digene Corporation and Gen-Probe Incorporated, are the other key players in the Middle East and Africa Non-Invasive Cancer Diagnostics market.
For the detailed information please follow the link:
https://www.marketdataforecast.com/market-reports/middle-east-and-africa-non-invasive-cancer-diagnostics-market-5561/
Scope of the Report:
The report offers an extensive examination of the business by giving the estimations of market potential and gauges with most extreme granularity. Along this, the variables persuasive in affecting the market flow and patterns are examined in detail at the item level. Further, the execution of the market at the territorial and nation level is evaluated and the prospects with high development potential are distinguished and discussed.
The key players in the business are profiled giving bits of knowledge on their money related execution, advertise position and development techniques. Similar investigation on prime strategical exercises of the market players depicting the key advancements like mergers and acquisitions, coordinated efforts and an assessment of the focused condition inside the business are given. The report additionally offers an expansive standpoint of the market alongside proposals from industry specialists on the open doors for speculation action.
What else? Aside from the syndicated report, our in-house group has an aptitude and involvement in planning custom reports to meet your particular research needs and help you in settling on very much educated choices.
Contact Info:
Name: Mr. Abhishek Shukla
Email: abhishek@marketdataforecast.com
Organization: MarketDataForecast™
Address: 2nd Floor, Above ICICI Bank, B-44, Rd Number 3, Journalist Colony, Film Nagar, Hyderabad, Telangana 500033, India.
Phone: +1-888-702-9626
Contact Information:
Market Data Forecast.
Abhishek Shukla
Tel: +1-888-702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Market Data Forecast.
Abhishek Shukla
Tel: +1-888-702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results